ADVANCING IMID SCIENCE
DEAD

Serial Number

85863208

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

Feb 28, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ADVANCING IMID SCIENCE Trademark

Serial Number: 85863208

ADVANCING IMID SCIENCE is a trademark filed by Celgene Corporation on February 28, 2013. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

February 28, 2013

Registration Date

Not Registered

Published for Opposition

June 4, 2013

Goods & Services

Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries

Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 3, 2014 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 3, 2014 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 1, 2013 PREV
ASSIGNED TO LIE
May 1, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2013 CNEA
ASSIGNED TO EXAMINER
Apr 17, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2013 NWOS
NEW APPLICATION ENTERED
Mar 4, 2013 NWAP